With 1.05 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.55 million shares. During the session, the Capital Markets company that operates in wider Financial sector, reached to the highest price of $6.95 whereas the lowest price it dropped to was $6.84. The 52-week range on NMR shows that it touched its highest point at $6.99 and its lowest point at $4.66 during that stretch. It currently has a 1-year price target of $7.08. With its current market cap of 20.42 billion, NMR has annualized dividend of $0.25 while the current yield stands at 3.60%. NMR paid its most recent dividend on 1190764800, while the ex-dividend date for that was 1727654400. Beta for the stock currently stands at 0.62.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of NMR was up-trending over the past week, with a rise of 7.13%, but this was up by 18.93% over a month. Three-month performance surged to 31.37% while six-month performance rose 37.10%. The stock gained 25.87% in the past year, while it has gained 19.34% so far this year. A look at the trailing 12-month EPS for NMR yields 0.70 with Next year EPS estimates of 0.67. For the next quarter, that number is 0.18. This implies an EPS growth rate of 89.97% for this year and -0.19% for next year.
Float and Shares Shorts:
At present, 2.96 billion NMR shares are outstanding with a float of 2.96 billion shares on hand for trading. On 2025-01-15, short shares totaled 0.41 million, which was 1.0 higher than short shares on 1734048000. In addition to Mr. Kentaro Okuda as the firm’s President, Group CEO, Representative Executive Officer & Director, Mr. Takumi Kitamura serves as its CFO, Executive Officer & Chief Transformation Officer.
Institutional Ownership:
Through their ownership of 0.022909999 of NMR’s outstanding shares, institutional investors have minority control over the company.
Analysts Ratings:
In the same way, a target price assigned to a stock can also reveal much about its potential. With NMR analysts setting a high price target of 7.17773 and a low target of 7.17773, the average target price over the next 12 months is 7.17773. Based on these targets, NMR could surge 3.87% to reach the target high and rise by 3.87% to reach the target low. Reaching the average price target will result in a growth of 3.87% from current levels.
Analysts have provided yearly estimates in a range of $57.07128 being high and $52.18842 being low. For NMR, this leads to a yearly average estimate of $54.48406. Based on analyst estimates, the high estimate for the next quarter is $0 and the low estimate is $0. The average estimate for the next quarter is thus $0.
